Solventum
SOLV • NYSE
Solventum is a medical - care facilities company in the healthcare sector trading on NYSE, led by CEO Bryan C. Hanson, with a market cap of $10.9B.
CEOBryan C. Hanson
Next Earnings
Upcoming earnings announcement for Solventum
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.35
Revenue Estimate
$2.0B
Earnings History
Past 8 earnings reports for Solventum
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | $1.57Est: $1.50 | +4.7% | $2.0BEst: $2.0B | +1.8% |  10-K |
| Nov 6, 2025 | Q3 2025 | $1.50Est: $1.43 | +4.9% | $2.1BEst: $2.1B | +1.4% | 10-Q |
| Aug 7, 2025 | Q2 2025 | $1.69Est: $1.45 | +16.6% | $2.2BEst: $2.1B | +2.0% | 10-Q |
| May 8, 2025 | Q1 2025 | $1.34Est: $1.22 | +9.8% | $2.1BEst: $2.0B | +2.5% | 10-Q |
| Feb 27, 2025 | Q4 2024 | $1.41Est: $1.32 | +6.8% | $2.1BEst: $2.1B | +1.2% | 10-K |
| Nov 7, 2024 | Q3 2024 | $1.64Est: $1.39 | +18.0% | $2.1BEst: $2.1B | +1.1% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $1.56Est: $1.50 | +4.0% | $2.1BEst: $2.1B | +1.5% | 10-Q |
| May 9, 2024 | Q1 2024 | $2.08Est: $1.74 | +19.5% | $2.0BEst: $2.0B | -0.2% | 10-Q |